Document Detail


Bupropion as an aid to smoking cessation: a review of real-life effectiveness.
MedLine Citation:
PMID:  15117097     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Clinical trials rigorously demonstrate the efficacy of new products and justify their marketing. However, it is only after use in real-life settings that the clinical value (effectiveness) of a new treatment is fully known. The purpose of this review was to summarise the effectiveness data for bupropion SR as an aid to smoking cessation. Available reports of effectiveness data for bupropion SR were obtained from the literature, presentations at smoking cessation meetings and from the manufacturer. Twelve sources of effectiveness data were found and included clinical practice trials, observational studies/surveys, motivational support programme results and employer-based cessation programme results. The 6-month point prevalence smoking cessation rates ranged from 25 to 49%. There is a growing body of evidence supporting the effectiveness of bupropion SR as an aid to smoking cessation. Real-life quit rates for bupropion SR are similar to those seen in the original clinical trial programme.
Authors:
S Holmes; N Zwar; C A Jiménez-Ruiz; P J Ryan; D Browning; L Bergmann; J A Johnston
Related Documents :
10876277 - The use of adcon-t/n glycosaminoglycan gel in the revision of tethered scars.
632357 - The case for laboratory aides in district clinical chemistry departments.
17019137 - Preemptive analgesia: an unsolved problem.
6334447 - Increase in relevant data after introduction of a problem-oriented record system in pri...
12287527 - Conditions and problems of the labour force in agriculture.
2796747 - The relation between problem categorization and problem solving among experts and novices.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of clinical practice     Volume:  58     ISSN:  1368-5031     ISO Abbreviation:  Int. J. Clin. Pract.     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-04-30     Completed Date:  2004-07-06     Revised Date:  2007-02-14    
Medline Journal Info:
Nlm Unique ID:  9712381     Medline TA:  Int J Clin Pract     Country:  England    
Other Details:
Languages:  eng     Pagination:  285-91     Citation Subset:  IM    
Affiliation:
Fairfield Hospital, Fairfield, NSW, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bupropion / therapeutic use*
Dopamine Uptake Inhibitors / therapeutic use*
Evidence-Based Medicine
Humans
Smoking Cessation / methods*
Tobacco Use Disorder / drug therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Dopamine Uptake Inhibitors; 34841-39-9/Bupropion

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current perspectives on the treatment of venous thromboembolism: need for effective, safe and conven...
Next Document:  Fatal meningitis due to Listeria monocytogenes in elderly patients with underlying malignancy.